• View Press Releases

    View Press Releases

News & Media

Recent News

View All News


  • The U.S. FDA granted Priority Review of the Biologics License Application for our investigational agent in advanced… twitter.com/i/web/status/1… · 1 day ago
  • Today is World Lymphoma Awareness Day! We’re wearing red to show our support and dedication to those impacted by… twitter.com/i/web/status/1… · 1 day ago

Quick Facts

Year founded 1998

Public Company Nasdaq:SGEN

Number of Employees 1,300+

Global Headquarters Bothell, WA

European Office Zug, Switzerland


Approved Product ADCETRIS® (brentuximab vedotin)


Disease Focus Areas Hodgkin lymphoma, non-Hodgkin lymphoma, urothelial cancer, breast cancer, cervical cancer


ADC Collaborations Multiple ADC technology licensing agreements; co-development collaborations with other oncology industry leaders


Social Media


Media Contacts

For Media Professionals Only

Monique Greer, Vice President Corporate Communications